-
A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160.
Science. 1989 Oct 6;246(4926):118-21
PMID: 2789433
-
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
Proc Natl Acad Sci U S A. 1989 Sep;86(17):6768-72
PMID: 2771954
-
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
Nature. 1990 Jun 14;345(6276):622-5
PMID: 2190095
-
Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.
J Virol. 1990 Jul;64(7):3492-9
PMID: 2191152
-
Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding.
J Virol. 1990 Dec;64(12):5701-7
PMID: 2243375
-
Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain.
J Virol. 1991 Jan;65(1):190-4
PMID: 1985197
-
Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene.
Nature. 1991 Jan 10;349(6305):167-9
PMID: 1986308
-
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):542-6
PMID: 1988952
-
Reduction in CD4 binding affinity associated with removal of a single glycosylation site in the external glycoprotein of HIV-2.
Virology. 1991 Feb;180(2):853-6
PMID: 1989393
-
Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys.
J Virol. 1991 Apr;65(4):1843-54
PMID: 2002545
-
Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2.
J Gen Virol. 1991 Jun;72 ( Pt 6):1261-7
PMID: 1710645
-
Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.
Science. 1991 Jul 5;253(5015):71-4
PMID: 1905842
-
Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity.
Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6082-6
PMID: 2068087
-
Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
AIDS. 1991 Jul;5(7):829-36
PMID: 1716442
-
Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody.
J Virol. 1991 Nov;65(11):6188-93
PMID: 1717717
-
Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120.
Science. 1991 Oct 4;254(5028):105-8
PMID: 1718036
-
Hypothetical assignment of intrachain disulfide bonds for HIV-2 and SIV envelope glycoproteins.
AIDS Res Hum Retroviruses. 1991 Jun;7(6):495-9
PMID: 1931228
-
Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS.
J Virol. 1991 Dec;65(12):7025-31
PMID: 1942255
-
Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity.
J Virol. 1992 Jan;66(1):524-33
PMID: 1727497
-
Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells.
Virology. 1992 Jan;186(1):313-7
PMID: 1727607
-
Functional and immunological characterization of SIV envelope glycoprotein produced in genetically engineered mammalian cells.
AIDS Res Hum Retroviruses. 1991 Nov;7(11):889-98
PMID: 1760229
-
Identification of B-cell antigenic sites on HIV-2 gp125.
J Acquir Immune Defic Syndr. 1992;5(2):177-87
PMID: 1370692
-
Population sequence analysis of a simian immunodeficiency virus (32H reisolate of SIVmac251): a virus stock used for international vaccine studies.
AIDS Res Hum Retroviruses. 1992 Jan;8(1):77-88
PMID: 1736942
-
Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody.
Nature. 1992 Feb 20;355(6362):728-30
PMID: 1741059
-
The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1.
Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1418-22
PMID: 1371358
-
Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.
J Virol. 1992 Apr;66(4):1875-83
PMID: 1548744
-
Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge.
Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2175-9
PMID: 1549578
-
Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.
J Virol. 1992 Jun;66(6):3602-8
PMID: 1374810
-
B-cell epitope mapping of the entire SIVagm envelope glycoprotein including fine mapping of immunogenic regions.
J Acquir Immune Defic Syndr. 1992;5(6):583-90
PMID: 1375290
-
Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies.
AIDS Res Hum Retroviruses. 1992 Jun;8(6):1147-51
PMID: 1380261
-
Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region.
J Virol. 1992 Dec;66(12):6997-7004
PMID: 1279195
-
Studies on the role of the V3 loop in human immunodeficiency virus type 1 envelope glycoprotein function.
AIDS Res Hum Retroviruses. 1992 Sep;8(9):1611-8
PMID: 1457207
-
Pathogenesis of human immunodeficiency virus infection.
Microbiol Rev. 1993 Mar;57(1):183-289
PMID: 8464405
-
Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop.
J Virol. 1993 Aug;67(8):4785-96
PMID: 7687303
-
Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry.
Virology. 1993 Jul;195(1):167-74
PMID: 8317093
-
SIV vaccines, 1991--a year in review.
AIDS. 1991;5 Suppl 2:S115-27
PMID: 1845043
-
Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys.
Nature. 1986 May 22-28;321(6068):435-7
PMID: 3012358
-
Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses.
Nature. 1987 Aug 6-12;328(6130):539-43
PMID: 3497350
-
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.
Proc Natl Acad Sci U S A. 1988 May;85(9):3198-202
PMID: 2452447
-
Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1.
J Virol. 1988 Oct;62(10):3695-702
PMID: 2458487
-
Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4.
J Virol. 1988 Nov;62(11):4195-200
PMID: 2845130
-
Cross-neutralizing antibodies against HIV-1 (HTLV-IIIB and HTLV-IIIRF) and HIV-2 (SBL-6669 and a new isolate SBL-K135).
AIDS Res Hum Retroviruses. 1989 Oct;5(5):525-33
PMID: 2590556